NCT06689033

Brief Summary

The administration of supplemental oxygen using a standard nasal cannula is the current standard of care for patients undergoing sedation for gastrointestinal endoscopic procedures. Endoscopic Retrograde Cholangio Pancreatography can be particularly challenging for anesthesiologists due to the increased difficulty in airway access when performed in the prone position. High-flow nasal oxygen is a non-invasive oxygen therapy system that can provide heated and humidified air containing oxygen at a high flow rate.This study aims to compare the effectiveness of High Flow Nasal Oxygen versus standard nasal oxygen in preventing hypoxemia in patients undergoing deep sedation during ERCP procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
187

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

October 28, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 14, 2024

Completed
Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

8 months

First QC Date

October 28, 2024

Last Update Submit

November 13, 2024

Conditions

Keywords

HFNOsedationprone positionCholangiopancreatography, Endoscopic Retrograde

Outcome Measures

Primary Outcomes (1)

  • Oxygen saturation SpO2 levels of the cases in %

    Each patient was monitored with an oxygen saturation probe and SpO2 levels of the cases were recorded before induction of sedation and every 5 minutes, throughout the procedure. Hypoxemia was detected.

    Oxygen saturation levels were recorded before induction and every 5 minutes throughout the procedure that lasted around 30 minutes.

Secondary Outcomes (1)

  • Number of interventions over procedure time (number)

    Number of maneuvers performed throughout the procedure, that lasted around 30 minutes were recorded.

Other Outcomes (2)

  • Systolic, diastolic and mean blood pressures were recorded

    Blood pressure monitorization was performed before induction and every 5 minutes throughout the procedure that lasted around 30 minutes.

  • Heart beat was recorded in beats per minute

    Heart beat monitorization was performed before induction and every 5 minutes throughout the procedure that lasted around 30 minutes.

Study Arms (2)

Group 1: Patients sedated for ERCP, receiving nasal oxygen

Nasal Oxygen, preoxygenation with 100% oxygen for 3 min with an oxygen flow rate of 8 L.min-1 via a nasal cannula before induction and 100% oxygen with a flow rate of 5 L.min-1 throughout the procedure.

Group 2: Patients sedated for ERCP receiving high flow nasal oxygen

High flow nasal oxygen, preoxygenation with 100% oxygen with a flow rate of 40 L.min-1 for 3 min before induction and received 50% oxygen with a flow rate of 50 L.min-1.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for ERCP procedure under sedation in Ankara City Hospital's Gastrointestinal Endoscopy Colonoscopy Unit are included.

You may qualify if:

  • Voluntary patients over 18 years of age
  • ASA (American Society of Anaesthesiologists) I-IV risk scores

You may not qualify if:

  • Patients with altered mental status, dementia, cognitive disorders
  • Intubation
  • Tracheostomies
  • Need for oxygen therapy due to preexisting disease
  • Pregnancy
  • Recent history of nasal bleeding
  • Allergy to propofol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital, Department of Anesthesiology

Ankara, 06800, Turkey (Türkiye)

Location

Related Publications (8)

  • Carron M, Tamburini E, Safaee Fakhr B, De Cassai A, Linassi F, Navalesi P. High-flow nasal oxygenation during gastrointestinal endoscopy. Systematic review and meta-analysis. BJA Open. 2022 Oct 18;4:100098. doi: 10.1016/j.bjao.2022.100098. eCollection 2022 Dec.

    PMID: 37588780BACKGROUND
  • Sawase H, Ozawa E, Yano H, Ichinomiya T, Yano R, Miyaaki H, Komatsu N, Ayuse T, Kurata S, Sato S, Pinkham MI, Tatkov S, Ashizawa K, Nagata K, Nakao K. Respiratory support with nasal high flow without supplemental oxygen in patients undergoing endoscopic retrograde cholangiopancreatography under moderate sedation: a prospective, randomized, single-center clinical trial. BMC Anesthesiol. 2023 May 8;23(1):156. doi: 10.1186/s12871-023-02125-w.

    PMID: 37158818BACKGROUND
  • Zhang YX, He XX, Chen YP, Yang S. The effectiveness of high-flow nasal cannula during sedated digestive endoscopy: a systematic review and meta-analysis. Eur J Med Res. 2022 Feb 24;27(1):30. doi: 10.1186/s40001-022-00661-8.

    PMID: 35209948BACKGROUND
  • Douglas N, Ng I, Nazeem F, Lee K, Mezzavia P, Krieser R, Steinfort D, Irving L, Segal R. A randomised controlled trial comparing high-flow nasal oxygen with standard management for conscious sedation during bronchoscopy. Anaesthesia. 2018 Feb;73(2):169-176. doi: 10.1111/anae.14156. Epub 2017 Nov 24.

    PMID: 29171661BACKGROUND
  • Corral-Blanco M, Sayas-Catalan J, Hernandez-Voth A, Rey-Terron L, Villena-Garrido V. High-Flow Nasal Cannula Therapy as an Adjuvant Therapy for Respiratory Support during Endoscopic Techniques: A Narrative Review. J Clin Med. 2023 Dec 22;13(1):81. doi: 10.3390/jcm13010081.

    PMID: 38202089BACKGROUND
  • Cha B, Lee MJ, Park JS, Jeong S, Lee DH, Park TG. Clinical efficacy of high-flow nasal oxygen in patients undergoing ERCP under sedation. Sci Rep. 2021 Jan 11;11(1):350. doi: 10.1038/s41598-020-79798-7.

    PMID: 33432035BACKGROUND
  • Lee MJ, Cha B, Park JS, Kim JS, Cho SY, Han JH, Park MH, Yang C, Jeong S. Impact of High-Flow Nasal Cannula Oxygenation on the Prevention of Hypoxia During Endoscopic Retrograde Cholangiopancreatography in Elderly Patients: A Randomized Clinical Trial. Dig Dis Sci. 2022 Aug;67(8):4154-4160. doi: 10.1007/s10620-021-07272-z. Epub 2021 Nov 2.

    PMID: 34727281BACKGROUND
  • Kim SH, Bang S, Lee KY, Park SW, Park JY, Lee HS, Oh H, Oh YJ. Comparison of high flow nasal oxygen and conventional nasal cannula during gastrointestinal endoscopic sedation in the prone position: a randomized trial. Can J Anaesth. 2021 Apr;68(4):460-466. doi: 10.1007/s12630-020-01883-2. Epub 2021 Jan 6.

    PMID: 33403549BACKGROUND

MeSH Terms

Conditions

Hypoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ezgi Erkilic, Associate Professor

    Ankara Bilkent City Hospital, Department of Anesthesiology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2024

First Posted

November 14, 2024

Study Start

April 1, 2023

Primary Completion

November 30, 2023

Study Completion

November 30, 2023

Last Updated

November 14, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

Data will be shared after publication of the study. Study protocol, statistical analysis, study report will be shared if required by a researcher.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Beginning right after publication and ending 2 years after the publication of results
Access Criteria
Data required for research and meta-analysis will be shared.

Locations